Literature DB >> 9314343

Pediatric idiopathic anaphylaxis: experience with 22 patients.

A M Ditto1, J Krasnick, P A Greenberger, K J Kelly, K McGrath, R Patterson.   

Abstract

Idiopathic anaphylaxis in the pediatric population is being increasingly recognized, with symptoms (and therefore classifications) the same as those described in adults. We present a series of 22 patients with special attention to considerations relatively unique to the pediatric population. Prednisone, hydroxyzine, and albuterol were used to control symptoms and induce remission. No deaths occurred during treatment. One adolescent who presented with corticosteroid-dependent idiopathic anaphylaxis was diagnosed with undifferentiated somatoform-idiopathic anaphylaxis. Local physician reluctance to participate in management complicated care for some patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9314343     DOI: 10.1016/s0091-6749(97)70244-6

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  5 in total

Review 1.  Pathogenesis, newly recognized etiologies, and management of idiopathic anaphylaxis.

Authors:  James L Kuhlen; Yamini V Virkud
Journal:  Discov Med       Date:  2015-02       Impact factor: 2.970

2.  Omalizumab's role in the treatment of steroid dependent malignant idiopathic anaphylaxis.

Authors:  Öner Özdemir; Hayrunnisa Bekis Bozkurt; Bahri Elmas
Journal:  Turk Pediatri Ars       Date:  2017-06-01

Review 3.  Management Strategies Of Idiopathic Anaphylaxis In The Emergency Room: Current Perspectives.

Authors:  Michelle Le; Sofianne Gabrielli; Sarah De Schryver; Moshe Ben-Shoshan
Journal:  Open Access Emerg Med       Date:  2019-11-01

Review 4.  Idiopathic Anaphylaxis: a Perplexing Diagnostic Challenge for Allergists.

Authors:  Theo Gulen; Cem Akin
Journal:  Curr Allergy Asthma Rep       Date:  2021-02-09       Impact factor: 4.806

Review 5.  Idiopathic Anaphylaxis.

Authors:  Bright I Nwaru; Sangeeta Dhami; Aziz Sheikh
Journal:  Curr Treat Options Allergy       Date:  2017-06-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.